Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials

Table 6

Analysis of tumor progression. Number of patients experiencing tumor progression according to treatment.

Study name	Active treatment		Control		OR	95%-CI
	Progression	No progression	Progression	No progression
TML	129	275	186	220	0.55	0.42–0.74]
CORRECT	298	207	217	38	0.25	0.17–0.37]
BEBYP	28	64	39	53	0.59	0.32–1.09]
RAISE	139	397	167	369	0.77	0.59–1.01]
Overall	Test of heterogeneity: , , → random effect model				0.51	0.31–0.82]